Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-02 Sale | 2026-01-06 4:05 pm | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 15,565 | $80.67 | $1,255,684 | 23,393 (Direct) | View |
| 2025-12-24 Sale | 2025-12-30 4:26 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 6,000 | $82.51 | $495,089 | 859,741 (Indirect Direct) | View |
| 2025-12-16 Sale | 2025-12-18 4:09 pm | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 7,397 | $80.1 | $592,500 | 38,958 (Direct) | View |
| 2025-12-15 Sale | 2025-12-17 4:07 pm | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 22,946 | $81.26 | $1,864,678 | 128,832 (Indirect Direct) | View |
| 2025-12-16 Sale | 2025-12-17 4:07 pm | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 2,078 | $79.5 | $165,201 | 60,800 (Indirect Direct) | View |
| 2025-09-24 Sale | 2025-09-26 4:08 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 6,000 | $55.37 | $332,220 | 865,741 (Indirect Direct) | View |
| 2025-09-08 Sale | 2025-09-10 5:03 pm | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 27,116 | $57 | $1,545,612 | 153,778 (Indirect Direct) | View |
| 2025-08-11 Sale | 2025-08-13 4:32 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 6,000 | $50 | $300,000 | 871,741 (Indirect Direct) | View |
| 2025-06-17 Sale | 2025-06-18 4:07 pm | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 13,608 | $40.42 | $550,035 | 92,467 (Direct) | View |
| 2025-06-16 Sale | 2025-06-17 4:07 pm | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 1,006 | $41.08 | $41,326 | 35,600 (Indirect Direct) | View |
| 2025-06-09 Sale | 2025-06-11 4:50 pm | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 17,500 | $43.76 | $765,800 | 47,557 (Direct) | View |
| 2025-03-24 Sale | 2025-03-26 4:47 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 6,000 | $50 | $300,000 | 877,741 (Indirect Direct) | View |
| 2025-03-18 Sale | 2025-03-20 9:49 pm | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 10,565 | $47.88 | $505,856 | 65,057 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 9:49 pm | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 7,583 | $47.89 | $363,142 | 79,682 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 9:49 pm | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 9,686 | $47.88 | $463,766 | 51,712 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 9:48 pm | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 6,711 | $47.88 | $321,323 | 46,355 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 9:48 pm | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 24,216 | $48.03 | $1,163,050 | 883,741 (Indirect Direct) | View |
| 2025-03-18 Sale | 2025-03-20 9:48 pm | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 3,724 | $47.88 | $178,306 | 22,431 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-15 Exercise | 2026-01-14 7:32 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Goodrich Katherine Director | 2,233 | $0 | 6,700 (Direct) | View |
| 2025-12-16 Gift | 2025-12-18 4:09 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 1,425 | $0 | 79,658 (Direct) | View |
| 2025-12-15 Exercise | 2025-12-17 4:07 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 6,819 | $0 | 60,800 (Direct) | View |
| 2025-12-04 Gift | 2025-12-08 4:06 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 51,885 | $0 | 865,741 (Direct) | View |
| 2025-09-16 Gift | 2025-09-18 5:00 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 2,000 | $0 | 151,778 (Direct) | View |
| 2025-09-15 Exercise | 2025-09-16 4:06 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director | 1,334 | $0 | 10,700 (Direct) | View |
| 2025-06-16 Exercise | 2025-06-18 4:07 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 27,881 | $0 | 92,467 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-17 4:07 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Lin Elizabeth Yeu Chief Medical Officer | 3,350 | $0 | 35,600 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 4:05 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | CHAUDHURI BHASKAR Director | 3,350 | $0 | 16,194 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:05 pm | N/A 2035-06-11 | Tarsus Pharmaceuticals Inc. | TARS | CHAUDHURI BHASKAR Director | 7,494 | $0 | 16,194 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:05 pm | N/A 2035-06-11 | Tarsus Pharmaceuticals Inc. | TARS | Goodrich Katherine Director | 7,494 | $0 | 7,494 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 4:04 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director | 3,350 | $0 | 24,194 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:04 pm | N/A 2035-06-11 | Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director | 7,494 | $0 | 24,194 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 4:04 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director | 3,350 | $0 | 21,194 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:04 pm | N/A 2035-06-11 | Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director | 7,494 | $0 | 21,194 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 4:04 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director | 3,350 | $0 | 16,860 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:04 pm | N/A 2035-06-11 | Tarsus Pharmaceuticals Inc. | TARS | Morrison Scott W Director | 7,494 | $0 | 16,860 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 4:03 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 3,350 | $0 | 188,388 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-16 4:03 pm | N/A 2035-06-11 | Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director | 7,494 | $0 | 188,388 (Direct) | View |
| 2025-03-17 Exercise | 2025-03-18 9:40 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 16,038 | $0 | 50,215 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 9:40 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President/CEO and Board Chair | 102,790 | $0 | 1,022,571 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 9:39 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 37,770 | $0 | 93,553 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 9:39 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 38,426 | $0 | 102,212 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 9:39 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 42,528 | $0 | 132,718 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 9:38 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 41,914 | $0 | 120,768 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 4:01 pm | N/A 2032-06-15 | Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director | 7,000 | $0 | 13,350 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 4:01 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Goldberg Andrew D. Director | 7,000 | $12.89 | 13,350 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:20 pm | N/A 2035-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Whitfield Dianne C. Chief Human Resources Officer | 50,717 | $0 | 50,717 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:19 pm | N/A 2035-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Farrow Jeffrey S See Remarks | 50,717 | $0 | 50,717 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:19 pm | N/A 2035-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer | 55,789 | $0 | 55,789 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:19 pm | N/A 2035-03-04 | Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer | 50,717 | $0 | 50,717 (Direct) | View |